Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, B. D.
Right arrow Articles by Leeds, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, B. D., III
Right arrow Articles by Leeds, N. E.
Neurology 2000;54:914-920
© 2000 American Academy of Neurology


Articles

Brain volume in children with neurofibromatosis type 1

Relation to neuropsychological status

B. D. Moore, III, PhD, J. M. Slopis, MD, E. F. Jackson, PhD, A. E. De Winter, PhD and N. E. Leeds, MD

From the Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX.

Address correspondence and reprint requests to Dr. Bartlett D. Moore III, Division of Pediatrics (Box 87), University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030; e-mail: bmoore{at}mdanderson.org

OBJECTIVE: To determine characteristics of brain morphology in children and adolescents with neurofibromatosis type 1 and relate these characteristics to neuropsychological functioning.

BACKGROUND: Neurofibromatosis type 1 is associated with numerous CNS abnormalities and cognitive impairment. Abnormal high signal intensity visible on brain MRI, brain tumors, and macrocephaly are common. Research into links between neuroanatomic and cognitive features has been inconclusive.

METHODS: Fifty-two children and adolescents with neurofibromatosis type 1 were compared with 19 control subjects on several quantitative neuroanatomic and neuropsychological measures.

RESULTS: Total brain volume, especially gray matter, was significantly greater for neurofibromatosis type 1 subjects than the control subjects. Group differences in the ratio of gray matter to white matter were more prominent in younger than in older subjects. Volume of gray matter in the subjects with neurofibromatosis type 1 was related to their degree of learning disability. Corpus callosum size was significantly larger for subjects in the neurofibromatosis type 1 group, and diminished performance on measures of academic achievement and visual–spatial and motor skills were associated with greater regional corpus callosum size.

CONCLUSIONS: Neuroanatomic morphology and the developmental pattern of gray matter and white matter in subjects with neurofibromatosis type 1 differed from in control subjects. Some of these differences are related to the neuropsychological status of the neurofibromatosis type 1 group. We propose that delayed developmental apoptosis results in macrocephaly and a delay in the development of appropriate neuronal connections in children with neurofibromatosis type 1. We further propose that these morphologic delays are related to the cognitive profile of neurofibromatosis type 1.

Key words: Neurofibromatosis—Brain volume—Neuropsychology—Children




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
P. Nopoulos, V. A. Magnotta, A. Mikos, H. Paulson, N. C. Andreasen, and J. S. Paulsen
Morphology of the Cerebral Cortex in Preclinical Huntington's Disease
Am J Psychiatry, September 1, 2007; 164(9): 1428 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S.L. Zamboni, T. Loenneker, E. Boltshauser, E. Martin, and K.A. Il'yasov
Contribution of Diffusion Tensor MR Imaging in Detecting Cerebral Microstructural Changes in Adults with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 773 - 776.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. S. Greenwood, L. A. Tupler, J. K. Whitt, A. Buu, C. B. Dombeck, A. G. Harp, M. E. Payne, J. D. Eastwood, K. R. R. Krishnan, and J. R. MacFall
Brain Morphometry, T2-Weighted Hyperintensities, and IQ in Children With Neurofibromatosis Type 1
Arch Neurol, December 1, 2005; 62(12): 1904 - 1908.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Feldmann, J. Denecke, M. Grenzebach, G. Schuierer, and J. Weglage
Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities
Neurology, December 23, 2003; 61(12): 1725 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. L. Billingsley, E. F. Jackson, J. M. Slopis, P. R. Swank, S. Mahankali, and B. D. Moore
Functional Magnetic Resonance Imaging of Phonologic Processing in Neurofibromatosis 1
J Child Neurol, November 1, 2003; 18(11): 731 - 740.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Raine, T. Lencz, K. Taylor, J. B. Hellige, S. Bihrle, L. Lacasse, M. Lee, S. Ishikawa, and P. Colletti
Corpus Callosum Abnormalities in Psychopathic Antisocial Individuals
Arch Gen Psychiatry, November 1, 2003; 60(11): 1134 - 1142.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S.L. Hyman, D.S. Gill, E.A. Shores, A. Steinberg, P. Joy, S.V. Gibikote, and K.N. North
Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1
Neurology, April 8, 2003; 60(7): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
G. W. Schrimsher, R. L. Billingsley, E. F. Jackson, and B. D. Moore
Caudate Nucleus Volume Asymmetry Predicts Attention-Deficit Hyperactivity Disorder (ADHD) Symptomatology in Children
J Child Neurol, December 1, 2002; 17(12): 877 - 884.
[Abstract] [PDF]


Home page
NeurologyHome page
L.E. Cutting, K.L. Cooper, C.W. Koth, S.H. Mostofsky, W.R. Kates, M.B. Denckla, and W.E. Kaufmann
Megalencephaly in NF1: Predominantly white matter contribution and mitigation by ADHD
Neurology, November 12, 2002; 59(9): 1388 - 1394.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
K. North, S. Hyman, and B. Barton
Review Article : Cognitive Deficits in Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 605 - 612.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. L. Billingsley, G. W. Schrimsher, E. F. Jackson, J. M. Slopis, and B. D. Moore III
Significance of Planum Temporale and Planum Parietale Morphologic Features in Neurofibromatosis Type 1
Arch Neurol, April 1, 2002; 59(4): 616 - 622.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. G. Steen, J. S. Taylor, J. W. Langston, J. O. Glass, V. R. Brewer, W. E. Reddick, R. Mages, and E. K. Pivnick
Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 810 - 817.
[Abstract] [Full Text]


Home page
JCBHome page
R. Heumann, C. Goemans, D. Bartsch, K. Lingenhohl, P. C. Waldmeier, B. Hengerer, P. R. Allegrini, K. Schellander, E. F. Wagner, T. Arendt, et al.
Transgenic Activation of Ras in Neurons Promotes Hypertrophy and Protects from Lesion-Induced Degeneration
J. Cell Biol., December 25, 2000; 151(7): 1537 - 1548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.